IMMUNOCORE HLDGS ADS/1 (6YG) — Free Cash Flow Generation Index
IMMUNOCORE HLDGS ADS/1 (6YG) has a Free Cash Flow Generation Index of 0.98x as of June 2025. Free cash flow of €25.55 Million represents 1% of operating cash flow (€25.96 Million). Read IMMUNOCORE HLDGS ADS/1 total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
IMMUNOCORE HLDGS ADS/1 Free Cash Flow Generation Index (2023–2024)
Historical FCF Generation Index trend for IMMUNOCORE HLDGS ADS/1 across 2 annual periods. Explore 6YG capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for IMMUNOCORE HLDGS ADS/1 (2023–2024)
Year-by-year Free Cash Flow Generation Index for IMMUNOCORE HLDGS ADS/1. For the full company profile including market capitalisation, see IMMUNOCORE HLDGS ADS/1 stock valuation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.80x | €20.89 Million | €26.06 Million | €5.17 Million | ▲ +194.8% |
| 2023 | -0.85x | €-2.48 Million | €2.94 Million | €5.42 Million | — |